Jennifer Crowley highlighted a VA-wide initiative that reduced combined antithrombotic therapy (CAT) use to minimize bleeding risk, emphasizing guideline-based de-prescribing and PPI use, which can cut GI bleed risk by 50%. She also cited updated ACCA guidelines recommending limited durations for dual and triple therapy. Presented at 2025 SPS Puerto Rico.